- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Zydus Wellness consolidated annual net sales up by 12.8 percent at Rs 2243 crores
Five of its brands, Glucon-D, Sugar Free, EverYuth Scrub, Peel Off Face Mask and Nycil maintained their leadership positions in their respective categories as on March 2023.
Ahmedabad: Zydus Wellness Ltd., has announced results for the fourth quarter ended March 31st 2023. The company reported 11.8% growth in consolidated net sales which stood at Rs. 709.9 crores. The Company reported consolidated income from operations at Rs. 713.0 crores, up by 11.4%.
EBIDTA was up by 2.2% y-o-y to Rs. 144.6 crores. Adjusted Net Profit (before exceptional items) stood at Rs.152.5 crores up by 14.4% as compared to the comparable corresponding quarter of the previous year. On an annual basis, the company posted total income from operations of Rs. 2242.6 crores, up by 12.8 % y-o-y and adjusted Net Profit (before exceptional items), up by 3.7% y-o-y.
Five of its brands, Glucon-D, Sugar Free, EverYuth Scrub, Peel Off Face Mask and Nycil maintained their leadership positions in their respective categories as on March 2023. For the first time ever, Glucon-D has crossed 60 percent market share during the financial year. The brand maintained its number one position with a market share of 60.1% as per MAT March 2023 report of Nielsen, registering an increase of 159 basis points over the same period last year. The company launched various extensions in the brand portfolio like sachets, kachha mango under Immunovolts and mango blast flavour under flavoured glucose powder during the year.
Nycil has maintained its dominant position by further increasing it’s market share by 157 basis points over the same period last year, which now stood at 35.4% in the Prickly heat powder category as per MAT March 2023 report of Nielsen. The brand registered a robust growth for the financial year.
Everyuth brand continues to outpace category growth during the financial year. The company continued to focus on the core portfolio of face wash, scrubs, peel-off and body lotions through TV and digital campaigns throughout the year.
"Everyuth Scrub has increased by 68 basis point at MAT level over same period last year to 41.9% further strengthening it’s leadership position in the facial scrub category and Everyuth Peel off has maintained its number one position with a market share of 78.4 % in the Peel off as per MAT March 2023 report of Nielsen," the company stated.
Nutralite brand continued to grow stronger during the financial year with support of the digital and on-ground activations.
Read also: Zydus Lifesciences bags USFDA nod for hypotension injection Ephedrine Sulfate
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751